Novartis, Artios cancer discovery deal worth up to $1.3bn
The collaboration centers on development of precision cancer treatments, through discovery and validation of next-generation DNA damage response targets.
Archives for April 12, 2021
Decentralized trials call for supply chain flexibility: Marken
Leaders from the supply chain solutions company share their thoughts on challenges associated with virtual and hybrid trials, and the COVID-19 pandemic.
Positive study results said to support deployment of assay system in cancer drug clinical trials
New research findings suggest that an immunotherapy assay enables determination of PD-L1 status in a high percentage of cancer patients and could guide personalized treatment selection.